Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...

Ulta Beauty ( ULTA) was the best-performing stock in the S&P 500 after the beauty products retailer beat profit and sales ...

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...

The votes are in, and just two restaurants remain in our Best BBQ in Memphis bracket. Before voting restarts June 2, here is a look at the matchup.

Pre-eminent medical journals of the world are "in bed" with larger pharmaceutical companies, the HHS secretary said.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We assign Veeva’s commercial solutions a wide moat based on customer switching costs. Veeva CRM is Veeva’s cloud-based customer relationship management platform. It markets to pharmaceutical and ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...